Medical journal, Armed Forces India · 2024
Comparison of clinicodemographic characteristics in patients with selective serotonin reuptake inhibitors poisoning: A cross-sectional study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eizadi-Mood Nastaran, Miranzade Nastaran, Haddad Shadi, Aliabadi Maryam Ghasemi, Golshiri Parastoo, Meamar Rokhsareh
Аннотация
BACKGROUND: Our objective of this study was to evaluate patients of Selective Serotonin Reuptake Inhibitors (SSRIs) overdose and compare the toxicological effects of citalopram overdose with other SSRIs in adult poisoning cases.
METHODS: This cross-sectional study focused on acute, known-type SSRI ingestions. Demographic and toxicological data were collected on the patients. The outcomes analyzed were length of hospital stay, coma, seizures, electrocardiographic abnormalities, abnormal heart examination, and the presence of serotonin syndrome.
RESULTS: There were a total of 199 cases, with 165 (82.9%) being women. The majority of cases (n = 76, 38.2%) were attributed to citalopram, followed by sertraline (n = 67, 33.7%), fluoxetine (n = 33, 16.6%), fluvoxamine (n = 10, 5%), escitalopram (n = 6, 3%), paroxetine (n = 1, 0.5%), and mixed (n = 6, 3%). The most common symptoms were nausea and vomiting (n = 96, 48.2%). Most patients (58.3%) were conscious, with only 7 patients (3.5%) experiencing seizures. Among those with seizures, six patients had taken citalopram, with 50% of them ingesting 400 mg of citalopram. Tachycardia was observed in 62 (31.2%) patients, while no QT interval prolongation, PR interval changes, or arrhythmias were reported. Serotonin toxicity was noted in only 6 patients (3%), with 4 of them being poisoned with citalopram. The incidence of seizures with citalopram was significantly higher than with other SSRIs (odds ratio (OR) = 10.457; 1.6-2.88, P = 0.008), while nausea and vomiting were significantly more common in poisoning cases involving other SSRIs (OR = 0.51; 0.2-0.9, P = 0.02). There were no reported deaths.
CONCLUSION: Ingesting SSRIs results in minimal toxicity. However, seizures are more likely to occur with citalopram compared to other SSRIs.
METHODS: This cross-sectional study focused on acute, known-type SSRI ingestions. Demographic and toxicological data were collected on the patients. The outcomes analyzed were length of hospital stay, coma, seizures, electrocardiographic abnormalities, abnormal heart examination, and the presence of serotonin syndrome.
RESULTS: There were a total of 199 cases, with 165 (82.9%) being women. The majority of cases (n = 76, 38.2%) were attributed to citalopram, followed by sertraline (n = 67, 33.7%), fluoxetine (n = 33, 16.6%), fluvoxamine (n = 10, 5%), escitalopram (n = 6, 3%), paroxetine (n = 1, 0.5%), and mixed (n = 6, 3%). The most common symptoms were nausea and vomiting (n = 96, 48.2%). Most patients (58.3%) were conscious, with only 7 patients (3.5%) experiencing seizures. Among those with seizures, six patients had taken citalopram, with 50% of them ingesting 400 mg of citalopram. Tachycardia was observed in 62 (31.2%) patients, while no QT interval prolongation, PR interval changes, or arrhythmias were reported. Serotonin toxicity was noted in only 6 patients (3%), with 4 of them being poisoned with citalopram. The incidence of seizures with citalopram was significantly higher than with other SSRIs (odds ratio (OR) = 10.457; 1.6-2.88, P = 0.008), while nausea and vomiting were significantly more common in poisoning cases involving other SSRIs (OR = 0.51; 0.2-0.9, P = 0.02). There were no reported deaths.
CONCLUSION: Ingesting SSRIs results in minimal toxicity. However, seizures are more likely to occur with citalopram compared to other SSRIs.